QCM Cayman’s Idexx Laboratories IDXX Stock Holding History

QCM Cayman’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-682	Closed	-$373K	–	63
2022 Q1	$373K	Buy	+682	New	+$359K	1.63%	15
2020 Q3	–	Sell	-624	Closed	-$206K	–	192
2020 Q2	$206K	Buy	+624	New	+$181K	0.47%	101
2018 Q4	–	Sell	-1,416	Closed	-$354K	–	160
2018 Q3	$354K	Buy	+1,416	New	+$344K	1.16%	26

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

QCM Cayman's IDXX Position: Q2 2022 in Review

QCM Cayman sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 682 shares — an estimated $373K sold.

QCM Cayman first reported a position in IDXX in Q3 2018 and held it in 3 quarters. The position peaked at $373K in Q1 2022. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

QCM Cayman reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
QCM Cayman sold 682 Idexx Laboratories shares in Q2 2022, an estimated $373K.
QCM Cayman first reported a position in Idexx Laboratories in Q3 2018 and held it in 3 quarters.
QCM Cayman's Idexx Laboratories position peaked at $373K in Q1 2022.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on QCM Cayman's 13F filing for Q2 2022, filed 27 Jul 2022.